Quentin Jacquinot

发表

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

X. Pivot, B. Degano, D. Vernerey, 2022, Frontiers in Cardiovascular Medicine.

There is a need for a complete consideration of overall movement behaviors for the prevention, treatment, and follow-up of cancer risks and patients

A. Rossary, L. Delrieu, D. Thivel, 2022, Frontiers in Public Health.

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma

C. Borg, D. Vernerey, G. Mouillet, 2021, Frontiers in Oncology.

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

X. Pivot, B. Degano, D. Vernerey, 2017, BMC Cancer.

Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumab.

M. Espié, G. Romieu, I. Pauporté, 2018, Breast.

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

X. Pivot, B. Degano, D. Vernerey, 2017, BMC Cancer.

Physical exercise program, a strategy to prevent cardiotoxicity in early breast cancer: A literature review

B. Degano, F. Mougin, N. Méneveau, 2018, Movement & Sport Sciences - Science & Motricité.

A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study

S. Galli, D. Vernerey, M. Paillard, 2023, BMC Cancer.

Exercise Intervention on Insomnia in Patients with a Cancer: A Systematic Review of the Literature

N. Méneveau, Quentin Jacquinot, Chloé Drozd, 2024, Cancers.